Medical Director Service Excellence and Core Values Award (Davita Dialysis Inc. - 2013)
Best Teacher Award (Division of Nephrology, University of South Florida - 2007)
Alpha Omega Alpha (Honor Medical Society - 1989)
Memberships
Member (Davita Dialysis Physician Advisory Board, 2012 - Present)
Committee Member (Moffitt Cancer Center, 2009 - Present)
Member (VISN 8 Hypertension Committee, 1998 - 2006)
Member (Research and Development Committee, 1999 - 2000)
Member (Hypertension Ad Hoc Committee, 1995 - 2000)
Recent Publications
Talreja N, Butt A, Valle RL, Fox RW, Lockey RF. Successful desensitization to agalsidase beta after anaphylaxis.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology. 112(1) : 71-2, 2014.
ALLHAT Study Group. Major Outcomes in Moderately Hypercholesterolemic,
Hypertensive Patients Randomized to Pravastatin (ALLHAT-LLT).JAMA. 288(23) : 2998-3007, 2002.
ALLHAT Study Group. Major Outcomes in High Risk Hypertensive Patients
Randomized to Angiotensin-Converting Enzyme or Calcium Channel Blocker vs Diuretic
(ALLHAT).JAMA. 288(23) : 2981-2997, 2002.
ALLHAT Study Group. Major Cardiovascular Events in Hypertensive Patients
Randomized to Doxasozin vs. Chlortalidone.JAMA. 283(15) : 1967-1975, 2000.
Positions Held
Acting Program Director (Nephrology Fellowship, College of Medicine, University of South Florida 1999 - 2000)
Acting Director (Division of Nephrology, University of South Florida 1999 - 2000)
